High sensitivity C-reactive protein and cardfiac resynchronization therapy in patients with advanced heart failure.

Abstract

Our findings demonstrated that measurement of baseline and follow-up hsCRP levels may be useful as prognostic markers for timely potential risk stratification and subsequent appropriate treatment strategies in patients with advanced HF undergoing CRT.